| Dr Ira Lawrence Snider, DO | |
|
4222 N 12th St Ste 102, Phoenix, AZ 85014-6023 | |
| (602) 265-4357 | |
| (602) 604-9352 |
| Full Name | Dr Ira Lawrence Snider |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 51 Years |
| Location | 4222 N 12th St Ste 102, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992039093 | NPI | - | NPPES |
| 711680 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 4745 (Arizona) | Primary |
| 208D00000X | General Practice | L1417691 (Michigan) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoenician Medical Center Inc | 0547169708 | 34 |
News Archive
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing, and commercializing innovative pain treatments, today announced that researchers will be presenting scientific data on SPRIX (ketorolac tromethamine) Nasal Spray, Egalet-001, an abuse-deterrent, extended-release, oral morphine product candidate, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone product in development, at PainWeek 2015 to be held September 8 to 12 in Las Vegas, Nevada.
Antibiotics can leave the lung vulnerable to flu viruses, leading to significantly worse infections and symptoms, finds a new study in mice led by the Francis Crick Institute.
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
In the meantime, despite considering delaying the launch of the exchange, Maryland Gov. Martin O'Malley said Thursday that he is confident that problems with the website will be fixed and that the exchange will meet its goal of enrolling 260,000 by the end of March 2014.
Pfizer Inc. announced today the suspension of the osteoarthritis clinical program for the investigational compound tanezumab following a request by the U.S. Food and Drug Administration. The worldwide suspension – which is effective immediately – follows a small number of reports of tanezumab patients experiencing the worsening of osteoarthritis leading to joint replacement.
› Verified 6 days ago
| Entity Name | Phoenician Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891895637 PECOS PAC ID: 0547169708 Enrollment ID: O20040107000237 |
News Archive
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing, and commercializing innovative pain treatments, today announced that researchers will be presenting scientific data on SPRIX (ketorolac tromethamine) Nasal Spray, Egalet-001, an abuse-deterrent, extended-release, oral morphine product candidate, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone product in development, at PainWeek 2015 to be held September 8 to 12 in Las Vegas, Nevada.
Antibiotics can leave the lung vulnerable to flu viruses, leading to significantly worse infections and symptoms, finds a new study in mice led by the Francis Crick Institute.
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
In the meantime, despite considering delaying the launch of the exchange, Maryland Gov. Martin O'Malley said Thursday that he is confident that problems with the website will be fixed and that the exchange will meet its goal of enrolling 260,000 by the end of March 2014.
Pfizer Inc. announced today the suspension of the osteoarthritis clinical program for the investigational compound tanezumab following a request by the U.S. Food and Drug Administration. The worldwide suspension – which is effective immediately – follows a small number of reports of tanezumab patients experiencing the worsening of osteoarthritis leading to joint replacement.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ira Lawrence Snider, DO 1343 N Alma School Rd, Ste 160, Chandler, AZ 85224-5901 Ph: (480) 963-1853 | Dr Ira Lawrence Snider, DO 4222 N 12th St Ste 102, Phoenix, AZ 85014-6023 Ph: (602) 265-4357 |
News Archive
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing, and commercializing innovative pain treatments, today announced that researchers will be presenting scientific data on SPRIX (ketorolac tromethamine) Nasal Spray, Egalet-001, an abuse-deterrent, extended-release, oral morphine product candidate, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone product in development, at PainWeek 2015 to be held September 8 to 12 in Las Vegas, Nevada.
Antibiotics can leave the lung vulnerable to flu viruses, leading to significantly worse infections and symptoms, finds a new study in mice led by the Francis Crick Institute.
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
In the meantime, despite considering delaying the launch of the exchange, Maryland Gov. Martin O'Malley said Thursday that he is confident that problems with the website will be fixed and that the exchange will meet its goal of enrolling 260,000 by the end of March 2014.
Pfizer Inc. announced today the suspension of the osteoarthritis clinical program for the investigational compound tanezumab following a request by the U.S. Food and Drug Administration. The worldwide suspension – which is effective immediately – follows a small number of reports of tanezumab patients experiencing the worsening of osteoarthritis leading to joint replacement.
› Verified 6 days ago
John Edward Lockhart, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1601 W Jefferson St, Phoenix, AZ 85007 Phone: 623-386-6160 | |
Bingfen Grace Yu, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 9150 W Indian School Rd, Suite 118, Phoenix, AZ 85037 Phone: 602-938-6960 Fax: 602-938-6069 | |
Dr. Travis Whitney, NMD General Practice Medicare: Not Enrolled in Medicare Practice Location: 4840 E Indian School Rd Ste 104, Phoenix, AZ 85018 Phone: 602-603-3118 | |
Dr. Ilya Katz, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 11022 N 28th Dr Ste 205, Phoenix, AZ 85029 Phone: 602-971-0304 Fax: 602-971-0305 | |
Burt Gary Feuerstein, General Practice Medicare: Not Enrolled in Medicare Practice Location: 10008 N 34th Pl, Phoenix, AZ 85028 Phone: 415-730-2526 | |
Terry Klemm, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 16251 N Cave Creek Rd, Phoenix, AZ 85032 Phone: 480-882-4545 Fax: 480-882-5004 | |
Dale Palmer, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 1601 W Jefferson St, Phoenix, AZ 85007 Phone: 623-853-0304 |